FS50237119: Difference between revisions

From FOIwiki
Jump to navigationJump to search
(XML import)
(CSV import)
Line 1: Line 1:
{{DNSummaryBox
{{DNSummaryBox
|dn_ref=FS50237119
|dn_ref=FS50237119
|dn_date=18/02/2010
|dn_date=18 February 2010
|dn_pa=Medicines and Healthcare Products Regulatory Agency
|dn_pa=Medicines and Healthcare Products Regulatory Agency
|dn_summary=al to the Information Tribunal.
|dn_summary=The complainant made a request under the Freedom of Information Act 2000 (the “Act”) to the Medicines and Healthcare Regulatory Authority (MHRA) for information it had redacted from pages 9 to 31 of an Assessment Report setting out the findings of a study conducted on the issue of mortality rates in Linezolid treated patients. The MHRA refused to disclose the requested information upon reliance of the exemptions contained at sections 40(2) and 41(1) of the Act. The Commissioner considers that the MHRA correctly applied the exemption contained at section 41(1) of the Act to withhold the requested information. As the Commissioner found that section 41(1) of the Act was correctly engaged he did not go on to consider the MHRA’s application of section 40(2) of the Act. The Commissioner does however consider that the MHRA breached sections 1(1)(a) and (b), section 10(1) and section 17(1) in its handling of this request. This decision notice is currently under appeal to the Information Tribunal.
|dn_url=http://www.ico.gov.uk/upload/documents/decisionnotices/2010/fs_50237119.pdf
|dn_url=http://www.ico.gov.uk/upload/documents/decisionnotices/2010/fs_50237119.pdf
}}
}}
{{DNDecision
{{DNDecision1
|dnd_section=FOI 10
|dnd_section=FOI 10
|dnd_finding=Upheld
|dnd_finding=Upheld
}}
}}
{{DNDecision
{{DNDecision2
|dnd_section=FOI 17
|dnd_section=FOI 17
|dnd_finding=Upheld
|dnd_finding=Upheld
}}
}}
{{DNDecision
{{DNDecision3
|dnd_section=FOI 41
|dnd_section=FOI 41
|dnd_finding=Not upheld
|dnd_finding=Not upheld
}}
}}

Revision as of 21:19, 15 May 2010


Decision Summary

  • Case Ref: FS50237119
  • Date: 18 February 2010
  • Public Authority: Medicines and Healthcare Products Regulatory Agency
  • Summary: The complainant made a request under the Freedom of Information Act 2000 (the “Act”) to the Medicines and Healthcare Regulatory Authority (MHRA) for information it had redacted from pages 9 to 31 of an Assessment Report setting out the findings of a study conducted on the issue of mortality rates in Linezolid treated patients. The MHRA refused to disclose the requested information upon reliance of the exemptions contained at sections 40(2) and 41(1) of the Act. The Commissioner considers that the MHRA correctly applied the exemption contained at section 41(1) of the Act to withhold the requested information. As the Commissioner found that section 41(1) of the Act was correctly engaged he did not go on to consider the MHRA’s application of section 40(2) of the Act. The Commissioner does however consider that the MHRA breached sections 1(1)(a) and (b), section 10(1) and section 17(1) in its handling of this request. This decision notice is currently under appeal to the Information Tribunal.
  • View PDF of Decision Notice: [1]

Template:DNDecision1 Template:DNDecision2 Template:DNDecision3